Google DeepMind's AlphaGenome is revolutionizing DNA analysis accuracy, especially in non-coding regions, through an AI breakthrough.
AlphaGenome can read up to a million base pairs of DNA at once, surpassing previous models, providing insights into the effects of mutations.
The AI innovation offers a deeper understanding of gene regulation and the impact of mutations in non-coding DNA on diseases, potentially transforming healthcare.
The technology holds promise for diagnosing genetic diseases quicker and enhancing drug discovery efforts.